Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12‐Week, Randomized, Controlled Study
Sign Up to like & getrecommendations! Published in 2021 at "Movement Disorders"
DOI: 10.1002/mds.28681
Abstract: Modulation of the endocannabinoid system via monoacylglycerol lipase inhibition with Lu AG06466 (formerly known as ABX‐1431) has previously been shown to reduce tics in patients with Tourette syndrome. read more here.
Keywords: monoacylglycerol lipase; syndrome week; inhibition tourette; lipase inhibition ... See more keywords